Biocon Biologics
Maninder Kaur has over a decade of experience in the pharmaceutical and biotechnology sectors, currently serving as Associate Scientific Manager II at Biocon Biologics since May 2018, where responsibilities include process development and technology transfer for large-scale manufacturing, alongside regulatory support. Prior roles at Biocon from January 2011 to April 2018 included Principal Scientist and Senior Scientist, where focus areas encompassed SVP analysis and collaboration across R&D, manufacturing, quality, and regulatory divisions. Earlier experience as a lecturer at Global Group of Institutions and a research fellow at the Indian Institute of Chemical Technology involved advanced research on drug delivery systems. Maninder Kaur holds a Master’s degree in Pharmaceutical Analysis from the National Institute of Pharmaceutical Education and Research and a Bachelor’s degree in Pharmacy from Guru Jambheshwar University.
This person is not in the org chart
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics